Cargando…
An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease
About 15% of patients with parkinsonism have a hereditary form of Parkinson’s disease (PD). Studies on the early stages of PD pathogenesis are challenging due to the lack of relevant models. The most promising ones are models based on dopaminergic neurons (DAns) differentiated from induced pluripote...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139404/ https://www.ncbi.nlm.nih.gov/pubmed/37108456 http://dx.doi.org/10.3390/ijms24087297 |
_version_ | 1785032940571328512 |
---|---|
author | Lebedeva, Olga S. Sharova, Elena I. Grekhnev, Dmitriy A. Skorodumova, Liubov O. Kopylova, Irina V. Vassina, Ekaterina M. Oshkolova, Arina Novikova, Iuliia V. Krisanova, Alena V. Olekhnovich, Evgenii I. Vigont, Vladimir A. Kaznacheyeva, Elena V. Bogomazova, Alexandra N. Lagarkova, Maria A. |
author_facet | Lebedeva, Olga S. Sharova, Elena I. Grekhnev, Dmitriy A. Skorodumova, Liubov O. Kopylova, Irina V. Vassina, Ekaterina M. Oshkolova, Arina Novikova, Iuliia V. Krisanova, Alena V. Olekhnovich, Evgenii I. Vigont, Vladimir A. Kaznacheyeva, Elena V. Bogomazova, Alexandra N. Lagarkova, Maria A. |
author_sort | Lebedeva, Olga S. |
collection | PubMed |
description | About 15% of patients with parkinsonism have a hereditary form of Parkinson’s disease (PD). Studies on the early stages of PD pathogenesis are challenging due to the lack of relevant models. The most promising ones are models based on dopaminergic neurons (DAns) differentiated from induced pluripotent stem cells (iPSCs) of patients with hereditary forms of PD. This work describes a highly efficient 2D protocol for obtaining DAns from iPSCs. The protocol is rather simple, comparable in efficiency with previously published protocols, and does not require viral vectors. The resulting neurons have a similar transcriptome profile to previously published data for neurons, and have a high level of maturity marker expression. The proportion of sensitive (SOX6+) DAns in the population calculated from the level of gene expression is higher than resistant (CALB+) DAns. Electrophysiological studies of the DAns confirmed their voltage sensitivity and showed that a mutation in the PARK8 gene is associated with enhanced store-operated calcium entry. The study of high-purity DAns differentiated from the iPSCs of patients with hereditary PD using this differentiation protocol will allow for investigators to combine various research methods, from patch clamp to omics technologies, and maximize information about cell function in normal and pathological conditions. |
format | Online Article Text |
id | pubmed-10139404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101394042023-04-28 An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease Lebedeva, Olga S. Sharova, Elena I. Grekhnev, Dmitriy A. Skorodumova, Liubov O. Kopylova, Irina V. Vassina, Ekaterina M. Oshkolova, Arina Novikova, Iuliia V. Krisanova, Alena V. Olekhnovich, Evgenii I. Vigont, Vladimir A. Kaznacheyeva, Elena V. Bogomazova, Alexandra N. Lagarkova, Maria A. Int J Mol Sci Article About 15% of patients with parkinsonism have a hereditary form of Parkinson’s disease (PD). Studies on the early stages of PD pathogenesis are challenging due to the lack of relevant models. The most promising ones are models based on dopaminergic neurons (DAns) differentiated from induced pluripotent stem cells (iPSCs) of patients with hereditary forms of PD. This work describes a highly efficient 2D protocol for obtaining DAns from iPSCs. The protocol is rather simple, comparable in efficiency with previously published protocols, and does not require viral vectors. The resulting neurons have a similar transcriptome profile to previously published data for neurons, and have a high level of maturity marker expression. The proportion of sensitive (SOX6+) DAns in the population calculated from the level of gene expression is higher than resistant (CALB+) DAns. Electrophysiological studies of the DAns confirmed their voltage sensitivity and showed that a mutation in the PARK8 gene is associated with enhanced store-operated calcium entry. The study of high-purity DAns differentiated from the iPSCs of patients with hereditary PD using this differentiation protocol will allow for investigators to combine various research methods, from patch clamp to omics technologies, and maximize information about cell function in normal and pathological conditions. MDPI 2023-04-14 /pmc/articles/PMC10139404/ /pubmed/37108456 http://dx.doi.org/10.3390/ijms24087297 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lebedeva, Olga S. Sharova, Elena I. Grekhnev, Dmitriy A. Skorodumova, Liubov O. Kopylova, Irina V. Vassina, Ekaterina M. Oshkolova, Arina Novikova, Iuliia V. Krisanova, Alena V. Olekhnovich, Evgenii I. Vigont, Vladimir A. Kaznacheyeva, Elena V. Bogomazova, Alexandra N. Lagarkova, Maria A. An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease |
title | An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease |
title_full | An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease |
title_fullStr | An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease |
title_full_unstemmed | An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease |
title_short | An Efficient 2D Protocol for Differentiation of iPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson’s Disease |
title_sort | efficient 2d protocol for differentiation of ipscs into mature postmitotic dopaminergic neurons: application for modeling parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139404/ https://www.ncbi.nlm.nih.gov/pubmed/37108456 http://dx.doi.org/10.3390/ijms24087297 |
work_keys_str_mv | AT lebedevaolgas anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT sharovaelenai anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT grekhnevdmitriya anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT skorodumovaliubovo anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT kopylovairinav anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT vassinaekaterinam anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT oshkolovaarina anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT novikovaiuliiav anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT krisanovaalenav anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT olekhnovichevgeniii anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT vigontvladimira anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT kaznacheyevaelenav anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT bogomazovaalexandran anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT lagarkovamariaa anefficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT lebedevaolgas efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT sharovaelenai efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT grekhnevdmitriya efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT skorodumovaliubovo efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT kopylovairinav efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT vassinaekaterinam efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT oshkolovaarina efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT novikovaiuliiav efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT krisanovaalenav efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT olekhnovichevgeniii efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT vigontvladimira efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT kaznacheyevaelenav efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT bogomazovaalexandran efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease AT lagarkovamariaa efficient2dprotocolfordifferentiationofipscsintomaturepostmitoticdopaminergicneuronsapplicationformodelingparkinsonsdisease |